论文部分内容阅读
采用静脉─静脉转流和驼背式方法，对36例肝脏肿瘤病人行同种异体肝移植，所有病人均获随访，最短存活1个月，最长存活26个月。16例术前术后诊断为原发性肝癌患者，均于一年内复发，一年生存率31％，三年生存率为零。认为，肿瘤体积与复发密切相关，对手术不能切除的肝癌，不应作为肝移植的适应证。
Allogeneic liver transplantation was performed on 36 patients with hepatic tumors using intravenous-venous bypass and hunchback methods. All patients were followed up, and they survived for 1 month and survived for a maximum of 26 months. 16 patients with preoperative and postoperative diagnosis of primary liver cancer recurred within one year, with a one-year survival rate of 31% and a three-year survival rate of zero. It is believed that tumor volume is closely related to recurrence, and liver cancer that cannot be removed by surgery should not be used as an indication for liver transplantation.